We are live on ! Find out more
BCAM

Boston Common Asset Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 28.29%
This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+28.29%
3 Year Est. Return
+54.94%
5 Year Est. Return
+54.02%
10 Year Est. Return
+260.31%
AUM
$4.81B
AUM Growth
+$2.71B
Cap. Flow
+$2.61B
Cap. Flow %
54.36%
Top 10 Hldgs %
14.03%
Holding
359
New
101
Increased
92
Reduced
89
Closed
64

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$18.7M
2
TSM icon
TSMC
TSM
+$18.1M
3
EW icon
Edwards Lifesciences
EW
+$15.3M
4
CAG icon
Conagra Brands
CAG
+$14M
5
TEL icon
TE Connectivity
TEL
+$13.9M

Top Sells

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$12M
2
TGT icon
Target
TGT
+$10.9M
3
KEY icon
KeyCorp
KEY
+$10.9M
4
MSFT icon
Microsoft
MSFT
+$9.83M
5
MRK icon
Merck
MRK
+$8.94M

Sector Composition

Rank Sector Weight
1 Healthcare 8.71%
2 Technology 8.25%
3 Financials 6.09%
4 Industrials 4.84%
5 Consumer Staples 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
201
AT&T
T
$162B
-25,522
Closed -$470K
TMO icon
202
Thermo Fisher Scientific
TMO
$214B
-1,564
Closed -$861K
TXN icon
203
Texas Instruments
TXN
$254B
-3,263
Closed -$539K
UNH icon
204
UnitedHealth
UNH
$367B
-3,374
Closed -$1.79M
UNP icon
205
Union Pacific
UNP
$175B
-2,947
Closed -$610K
WFC icon
206
Wells Fargo
WFC
$265B
-7,985
Closed -$330K

Similar funds

Boston Common Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Boston Common Asset Management held 359 positions worth $4.81B, up 130% from $2.09B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boston Common Asset Management deployed $2.61B of net new capital in Q1 2023, opening 101 new positions and adding to 92 existing holdings. Its largest new stake was Edwards Lifesciences: 194,369 shares worth $16.1M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was PNC Financial Services, an estimated $12M trimmed.

  • Boston Common Asset Management's largest Q1 2023 buy was Edwards Lifesciences: 194,369 shares worth $16.1M.
  • Boston Common Asset Management added most to AstraZeneca in Q1 2023, an estimated $18.7M increase.
  • Boston Common Asset Management's biggest Q1 2023 reduction was PNC Financial Services, cutting an estimated $12M.
  • Boston Common Asset Management fully exited Fidelity National Information Services in Q1 2023, selling an estimated $7.82M.
  • Boston Common Asset Management's ten largest holdings make up 14% of its $4.81B portfolio in Q1 2023.
  • Boston Common Asset Management opened 101 new positions and closed 64 in Q1 2023.
  • Boston Common Asset Management's portfolio value rose 130% quarter-over-quarter to $4.81B.

Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.